• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Pers Med . Long-Term Prognostic Impact of Right Ventricular Dysfunction in Patients with COVID-19

tetano

Editor, Senior Moderator
J Pers Med


. 2022 Jan 26;12(2):162.
doi: 10.3390/jpm12020162.
Long-Term Prognostic Impact of Right Ventricular Dysfunction in Patients with COVID-19


Fernando Scudiero[SUP] 1 [/SUP], Angelo Silverio[SUP] 2 [/SUP], Iacopo Muraca[SUP] 3 [/SUP], Vincenzo Russo[SUP] 4 [/SUP], Marco Di Maio[SUP] 2 [/SUP], Antonio Silvestro[SUP] 1 [/SUP], Davide Personeni[SUP] 1 [/SUP], Rodolfo Citro[SUP] 2 [/SUP], Mario Enrico Canonico[SUP] 5 [/SUP], Gennaro Galasso[SUP] 2 [/SUP], Italo Porto[SUP] 6 [/SUP], Guido Parodi[SUP] 5 [/SUP]



Affiliations

Abstract

The characteristics and clinical course of hospitalized patients with coronavirus disease 2019 (COVID-19) have been widely described, while long-term data are still poor. The aim of this study was to evaluate the long-term clinical outcome and its association with right ventricular (RV) dysfunction in hospitalized patients with COVID-19. This was a prospective multicenter study of consecutive COVID-19 patients hospitalized at seven Italian Hospitals from 28 February to 20 April 2020. The study population was divided into two groups according to echocardiographic evidence of RV dysfunction. The primary study outcome was 1-year mortality. The propensity score matching was performed to balance for potential baseline confounders. The study population consisted of 224 patients (mean age 69 ± 14, male sex 62%); RV dysfunction was diagnosed in 63 cases (28%). Patients with RV dysfunction were older (75 vs. 67 years, p < 0.001), had higher prevenance of coronary artery disease (27% vs. 11%, p = 0.003), and lower left ventricular ejection fraction (50% vs. 55%, p < 0.001). The rate of 1-year mortality (67% vs. 28%; p ≤ 0.001) was significantly higher in patients with RV dysfunction compared with patients without. After propensity score matching, patients with RV dysfunction showed a worse long-term survival (62% vs. 29%, p < 0.001). The multivariable Cox regression model showed an independent association of RV dysfunction with 1-year mortality. RV dysfunction is a relatively common finding in hospitalized COVID-19 patients, and it is independently associated with an increased risk of 1-year mortality.

Keywords: COVID-19; long-term outcome; right ventricular dysfunction.
 
Back
Top Bottom